Ensuring the success of advanced therapeutics requires reliable cryogenic storage to protect sensitive biological assets. Ultra-cold environments halt metabolic activity, allowing cells, tissues, and vectors to retain their potency and structure. This stability supports research, clinical trials, and large-scale bioproduction. With the growing demand for personalized and allogeneic th... https://hackmd.io/@xelleratherapeutics/HyXEpgseZl